**Core Concept**
Cholesterol synthesis is a complex biochemical pathway that involves multiple enzymes and intermediates. The rate-limiting step in cholesterol synthesis is a crucial regulatory point that controls the overall flux through the pathway. This step is mediated by a specific amino acid that serves as a substrate for the enzyme HMG-CoA reductase.

**Why the Correct Answer is Right**
The rate-limiting step in cholesterol synthesis is the conversion of HMG-CoA to mevalonate, which is catalyzed by the enzyme HMG-CoA reductase. This enzyme is highly regulated and is the target of several pharmacological interventions, including statins. The amino acid responsible for this rate-limiting step is **HMG-CoA**. HMG-CoA is synthesized from acetyl-CoA and acetoacetyl-CoA through a series of reactions, ultimately leading to the formation of HMG-CoA, which is then reduced to mevalonate by HMG-CoA reductase.

**Why Each Wrong Option is Incorrect**
**Option B:** This option is incorrect because it does not accurately represent the rate-limiting step in cholesterol synthesis. While other amino acids may be involved in cholesterol synthesis, HMG-CoA is the key substrate for HMG-CoA reductase.

**Option C:** This option is incorrect because it is not directly involved in the rate-limiting step of cholesterol synthesis. Other amino acids may be involved in downstream reactions, but they do not serve as the rate-limiting substrate.

**Option D:** This option is incorrect because it is not a relevant amino acid in the context of cholesterol synthesis. The correct amino acid is HMG-CoA, which is a key intermediate in the pathway.

**Clinical Pearl / High-Yield Fact**
Statins, which are commonly used to lower cholesterol levels, work by inhibiting HMG-CoA reductase, thereby reducing the synthesis of cholesterol. This highlights the importance of understanding the rate-limiting step in cholesterol synthesis and its regulation.

**Correct Answer:** A. HMG-CoA.